On January 9, as part of PhRMA’s sponsorship of Fierce JPM Week, PhRMA President and CEO Stephen J. Ubl joined Stephanie Butler for a conversation about patient access and affordability. During the conversation, Ubl dove into harmful policies impacting biopharmaceutical innovation, such as the Biden Administration’s recently proposed march-in rights framework, and offered policy solutions that would reduce out-of-pocket costs for patients, like reforms to middlemen known as pharmacy benefit managers (PBMs).

When:

January 9, 2024, at 11:55 AM PT

Speakers:

• Stephen J. Ubl, President and Chief Executive Officer, PhRMA
• Stephanie Butler, Senior Conference Production Director, Fierce Life Sciences (Moderator)